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This study investigated the phylogeny and molecular epidemiology of Australian porcine 
enterotoxigenic Escherichia coli (ETEC) isolates (n = 70) by performing multilocus sequence typing 
(MLST), random amplified polymorphic DNA (RAPD) analysis, virulence gene analysis, plasmid, 
bacteriocin, integron and antimicrobial resistance gene typing, and antimicrobial susceptibility 
phenotyping. Isolates of the most commonly observed O serogroup (O149) were highly clonal with a 
lower frequency of antimicrobial resistance compared with the less common O141 serogroup isolates, 
which were more genetically diverse and resistant to a greater array of antimicrobials. The O149 and 
O141 isolates belonged to sequence types (STs) ST100 and ST1260, respectively. A small number of 
new STs were identified for the least common serogroups, including O157 (ST4245), O138 (ST4244), 
O139 (ST4246) and O8 (ST4247). A high frequency of plasmid replicons was observed among all 
ETEC isolates. However, O149 isolates predominantly carried IncFIB, I1, HI1 and FIC, whereas 
O141 isolates carried a more varied array, including IncI1, FIB, FIC, HI1, I1, Y and, most 
significantly, A/C. O141 isolates also possessed a greater diversity of bacteriocins, with almost one-
half of the isolates carrying colicin E3 (44.4%; 12/27) and E7 (48.1%; 13/27). This study shows that 
Australian porcine ETEC are distinct from isolates obtained in other parts of the world with respect to 
the MLST profile and the absence of resistance to critically important antimicrobials, including third-
generation cephalosporins and fluoroquinolones. 




Enterotoxigenic Escherichia coli (ETEC) is the aetiological agent of both neonatal and post-weaning 
diarrhoea in pigs [1,2]. Neonatal diarrhoea occurs in piglets of 0–4 days of age and is typically 
associated with high morbidity and mortality [2,3]. ETEC strains that cause neonatal diarrhoea are 
usually non-β-haemolytic and belong to serogroups O8, O9, O20, O64, O149 or O101 [3,4]. By 
contrast, ETEC strains that cause post-weaning diarrhoea are usually β-haemolytic and belong to 
serogroups O8, O138, O139, O141, O145, O149 or O157 [1,4]. Both in neonatal and post-weaning 
diarrhoea, attachment of ETEC strains to the intestinal epithelium is mediated by the fimbrial adhesins 
F4 (K88), F5 (K99), F6 and F41 (neonatal diarrhoea) or F4 and F18 (post-weaning diarrhoea). 
Collectively, strains of these two groups of ETEC also release one or more of the heat-labile (LT) and 
heat-stable (STa and/or STb) enterotoxins, which induce hypersecretory diarrhoea [2,4]. Porcine 
ETEC virulence factors are typically encoded on F-type plasmids such as IncFIIA, FIB and FIC [5,6]. 
The occurrence of antimicrobial resistance (AMR) in porcine ETEC has been a longstanding problem 
in pig production [7,8]. Recently, there has been an increasing tendency for porcine ETEC to express 
a multidrug-resistant (MDR) phenotype [7,9]. With continuing use of antimicrobials, it is probable 
that at least some MDR ETEC will eventually develop pan-resistance, a phenotype that includes 
resistance to all commonly used drugs plus resistance to critical antimicrobials such as 
fluoroquinolones and third- and fourth-generation cephalosporins [7]. Recent studies have shown that 
fitness of drug-resistant ETEC in the pig production environment is aided by possession of specific 
virulence-associated plasmids in combination with resistance-associated plasmids [5]. Virulence 
genes are typically found on F-type plasmids, whereas resistance genes are encoded on IncFII-like 
IncFV, IncA/C and IncI1 plasmids [10]. 
The occurrence of antimicrobial resistance (AMR) in porcine ETEC has been a longstanding problem 
in pig production [7,8]. Recently, there has been an increasing tendency for porcine ETEC to express 
a multidrug-resistant (MDR) phenotype [7,9]. With continuing use of antimicrobials, it is probable 
that at least some MDR ETEC will eventually develop pan-resistance, a phenotype that includes 
resistance to all commonly used drugs plus resistance to critical antimicrobials such as 
fluoroquinolones and third- and fourth-generation cephalosporins [7]. Recent studies have shown that 
fitness of drug-resistant ETEC in the pig production environment is aided by possession of specific 
virulence-associated plasmids in combination with resistance-associated plasmids [5]. Virulence 
genes are typically found on F-type plasmids, whereas resistance genes are encoded on IncFII-like 
IncFV, IncA/C and IncI1 plasmids [10]. 
In addition to encoding for virulence factors and AMR, plasmids also encode for fitness factors such 
as bacteriocins, which may enhance colonisation capacity [11]. Bacteriocins are antibacterial peptides 
produced by bacteria to specifically inhibit or kill closely related species [11]. Bacteriocin-producing 
strains are themselves protected from the toxin owing to co-expression of an immunity factor 
(antitoxin) [11]. Bacteriocins therefore provide a competitive advantage to the producer strain and 
play an important role in intraspecific interactions within E. coli communities [11]. Colicins and 
microcins are the two types of bacteriocins produced by E. coli. Our recent studies have shown that 
commensal E. coli from the porcine gastrointestinal tract have distinctive bacteriocin profiles [12]. 
Although the key role of bacteriocins in the adaption of commensal E. coli to life in the gut is 
generally well understood, knowledge of their prevalence and distribution among porcine ETEC is 
currently lacking [11,12,13]. 
Due to the geographic isolation of Australia and the decades-long prohibition of the importation of 
livestock and fresh meat, the Australian porcine ETEC population has evolved in isolation from 
populations in other parts of the world. Australian porcine ETEC also are subject to less diverse 
antimicrobial selection pressures because of the restricted range of antimicrobials legally permitted 
for use in livestock in this country. For instance, Australia is the only country never to have permitted 
the use of fluoroquinolones and gentamicin in food-producing animals [14]. In addition, tight 
regulations govern the use of third-generation cephalosporins for mass medication, and fourth-
generation cephalosporins are not registered for use [9,15]. 
Our recent studies have focused on the prevalence of different serogroups, virulence genes and AMR 
genotypes and phenotypes among porcine ETEC associated with neonatal and post-weaning diarrhoea 
in Australia [4,9]. The objective of the present study was to examine the phylogeny and genetic 
relatedness of porcine ETEC strains as well as the prevalence and diversity of plasmid replicons and 
bacteriocins in clonally related lineages. The results of this study may provide unique insight into the 
role of plasmids encoding virulence and fitness factors as well as AMR in the evolution of strains 
from different genetic backgrounds in the Australian context. This may lead to the development of 
practical alternatives to antimicrobials for the treatment of ETEC, permitting the intensive 
management of pigs to remain sustainable. 
 
Materials and methods 
Bacterial strains 
In total, 70 ETEC strains were collected from clinical cases of neonatal (n = 7) and post-weaning 
(n = 63) diarrhoea from pigs in New South Wales (n = 33), Victoria (n = 14) and Queensland (n = 23). 
Isolates were collected from veterinary diagnostic laboratories between 1999 and 2005 
(Supplementary Table S1). These strains have been serogrouped as previously described [4]. The 
serogroups of the ETEC collection were as follows: O149 (n = 31); O141 (n = 27); O8 (n = 6); O20 
(n = 2); O109 (n = 1); O138 (n = 1); O139 (n = 1); and O157 (n = 1). For ease of discussion and due 
to low numbers, isolates belonging to serogroups other than O149 and O141 are jointly referred to as 
isolates of non-prominent serogroups (NPS). All O138, O139, O141 and O149 isolates were from 
cases of post-weaning diarrhoea, whereas the O20, O109 and three of the O8 isolates were from cases 
of neonatal diarrhoea. 
Maintenance of bacteria and DNA extraction 
Strains were grown overnight (ca. 16 h) in Luria–Bertani (LB) broth (Oxoid Australia, Adelaide, SA, 
Australia) at 37 °C with shaking at 200 rpm in an orbital shaker (Oxoid Australia). Bacterial strains 
were stored at −80 °C in LB broth containing 20% glycerol (Oxoid Australia). Strains from frozen 
stocks were recovered onto LB agar plates and single colonies were grown overnight (ca. 16 h) in LB 
broth for DNA extraction. Extraction of DNA was performed using 6% Chelex® (Bio-Rad, Sydney, 
NSW, Australia) as previously described [16]. 
Random amplified polymorphic DNA (RAPD) analysis 
RAPD analysis was carried out to assess the clonality of the porcine ETEC isolates using RAPD 
primers 1254 as previously described [12]. Gel-to-gel variations of the RAPD profiles were 
minimised by running the samples on one agarose gel (1.5%) at 120 V for 2 h. BioNumerics 6.1 
(Applied Maths, Sint-Martens-Latem, Belgium) was used to normalise the gels using the same DNA 
ladder (Gene Ruler 100 bp plus; Thermo Scientific, Adelaide, SA, Australia). 
Phylogenetic analysis 
Phylogenetic grouping was carried out using a multiplex PCR-based assay as described by Clermont 
et al. [17]. 
Multilocus sequence typing (MLST) 
Phylogenetic relationships of a subset (26/70) of porcine ETEC were determined using the E. 
coli scheme described at http://mlst.warwick.ac.uk/mlst/ [accessed 19 May 2014] [18]. The following 
seven genes were amplified and sequenced for MLST: adk; fumC; gyrB; icd; mdh; purA; and recA. 
Plasmid replicon typing 
Plasmid replicon typing was carried out to investigate the presence of 18 replicons using three 
multiplex and one uniplex PCR. These assays were performed using previously described 
primers [19], multiplex panels and reaction conditions as described previously [20]. 
Bacteriocin gene assay 
The presence of the following 16 bacteriocins was assessed for each strain using multiplex and 
uniplex reactions: colicins A, B, D, E1, E2, E3, E6, E7, Ia/Ib, K and M; and microcins B17, H47, J25, 
M and V. The assays were performed using previously described primers and reaction 
conditions [20]. 
Enterotoxigenic E. coli characterisation 
The ETEC pathotyping PCR was used to profile the signature virulence genes associated with porcine 
ETEC. The assay was carried out in one multiplex PCR reaction targeting the following eight ETEC 
virulence genes: stx2e; F4 (faeG); F6 (fasA); F18 (fedA); LT1 (eltb); F5 (fanA); STaP (estA); and STb 
(estB). The PCR reactions were performed as described by Casey and Bosworth [21]. 
Phenotypic detection of antimicrobial resistance 
Phenotypic detection of AMR was performed by disc diffusion using the Calibration Dichotomous 
Susceptibility (CDS) test Australia [22]. The following antimicrobials were tested: ampicillin (25 μg); 
amoxicillin/clavulanic acid (AMC) (60 μg); ticarcillin/clavulanic acid (85 μg); cefalexin (100 μg); 
cefoxitin (30 μg); cefotaxime (5 μg); cefepime (10 μg); nalidixic acid (30 μg); ciprofloxacin (2.5 μg); 
imipenem (10 μg); sulfisoxazole (sulfafurazole) (300 μg); trimethoprim (5 μg); tetracycline (10 μg); 
apramycin (15 μg); neomycin (30 μg); gentamicin (10 μg); azithromycin (15 μg); and 
chloramphenicol (30 μg). The CDS method is commonly used both in human and veterinary 
diagnostic microbiology laboratories within Australia and the breakpoints are calibrated by 
internationally standardised minimum inhibitory concentration (MIC) testing for each 
antimicrobial [22]. E. coli NCTC 10418 was used as the control strain [22]. Isolates resistant to three 
or more classes of antimicrobials were classified as MDR. 
Antimicrobial resistance gene (ARG) profiling 
A combination of three multiplex and eight uniplex PCR assays were performed to screen 25 ARGs 
commonly identified in E. coli [23]. The genes tested and the nucleotide sequences are described in 
Supplementary Table S2. 
Detection of integrons 
A multiplex PCR assay targeting class 1, 2 and 3 integrons (int1, int2 and int3) was performed to 
investigate the presence of integrons in the ETEC collection. This reaction was performed using 
previously described primers and conditions [24]. 
Statistical analysis 
BioNumerics 6.1 was used to perform principal coordinate analysis (PCA) using Dice correlation and 
complete linkage. RAPD profiles were assessed and compared using a band-based dendrogram 
created using Pearson correlation as the numeric coefficient with 0.5% position tolerance and 
unweighted pair-group mathematical average (UPGMA) clustering algorithm using BioNumerics 6.1. 
Fisher's exact test was used to assess the significance of differences in prevalence of traits (genetic 
and phenotypic) between the two major serogroups (O141 and O149). 
 
Results 
Random amplified polymorphic DNA profiling 
RAPD analysis separated the isolates into four major clusters and six independent branches that 
largely conformed to serogroup identity (Supplementary Fig. S1). The O149 and O141 isolates were 
divided into two separate clusters with the exception of three (atypical) O141 isolates. The NPS 
isolates were predominantly grouped into two separate clusters with the exception of four isolates that 
were clustered independently or intermingled among the O141 and O149 clusters. Interestingly, the 
three major clusters that separated O141, O149 and one group of NPS isolates shared 90% band 
similarity, whilst the remaining cluster representing NPS isolates only shared 50% band similarity 
(Supplementary Fig. S1). The NPS clusters that shared 90% homology with O141 and O149 clusters 
were all from cases of post-weaning diarrhoea, whereas one-half (5/10) of the isolates in the less 
related NPS cluster were from neonatal diarrhoea. In addition, O8 isolates from post-weaning 
diarrhoea were closely related to the O141 and O149 isolates, whereas the O8 isolates from neonatal 
diarrhoea were less closely related. 
Phylogenetic analysis 
Clermont phylogenetic grouping revealed that all O141 and O149 isolates belonged to phylogenetic 
group A. Serogroup O8 isolates belonged to diverse phylogenetic groups including B1, C and E 
(Supplementary Table S1). NPS isolates belonged to the following phylogenetic groups: O20 (A and 
E); O109 (B1); O138 (D); O139 (D); and O157 (C). 
Multilocus sequence typing 
All O149 isolates belonged to sequence type 100 (ST100), whereas all O141 isolates belonged to 
ST1260. The ST identities for the other serotypes were as follows: O109 (ST29); O8 (ST90, 120, 
410); and O20 (ST746). In addition, MLST identified new STs for the following serogroups: O157 
(ST4245); O138 (ST4244); O139 (ST4246); and O8 (ST4247). 
Comparison with and among serogroups 
No statistically meaningful comparisons could be made among the minor serogroups or between the 
minor subgroups and the O141 and O149 isolates, given the small sample sizes and the diverse 
genetic background of the minor serotypes. The characteristics of these isolates together with the 
O141 and O149 isolates are provided in Supplementary Table S1. 
Detection of plasmid replicon types 
Plasmid replicon typing identified 12 different plasmid types with all isolates carrying at least one or 
more plasmids (Table 1). IncI1 types were detected most frequently, followed by FIB, HI1 and FIC 
(Table 1). The IncFrepB group of F plasmids (FI, FII, FIII, FIV and FV) was present in all of the 
isolates. Of the Inc types detected, there was a significant difference in the carriage of IncFIB and A/C 
plasmid replicons between O149 and O141 serogroup isolates. IncA/C plasmid replicons that 
typically contain critical drug resistance genes such as those encoding resistance to third-generation 
cephalosporins and carbapenems [25] were only identified among O141 (14.8%; 4/27) and O139 
(n = 1) isolates. IncFIB replicons were more prevalent among O149 (96.8%; 30/31) compared with 
O141 isolates (59.3%; 16/27), whilst IncY replicons were more prevalent among O141 (18.5%; 5/27) 
compared with O149 isolates (6.5%; 2/31). In addition, plasmid replicons IncB/O FIA, H12, L/M and 
P were detected only in NPS isolates. Replicons IncFIIA, K/B, T, X and W were not detected. 
Detection of bacteriocin genes 
The bacteriocin gene assays targeting 16 colicin and microcin genes revealed that 65.7% of the 
isolates were positive for at least one bacteriocin gene. A total of 61.4% carried colicin genes whilst 
5.7% carried microcin genes. The most commonly detected bacteriocins were all colicins (Ia/Ib, E7, 
E3, B and M) (Table 1). Bacteriocin profiling revealed significant differences in carriage amongst 
isolates belonging to different ETEC serogroups (Table 1). The O141 isolates demonstrated greater 
diversity with nine bacteriocin profiles in comparison with four bacteriocin profiles for the O149 
serogroup isolates (Table 1). Approximately one-half of the O141 isolates carried colicins E3 (44.4%) 
and E7 (48.1%), whereas none of the O149 isolates carried these colicins. Colicins A, D, K and E6 
and microcins V, B17 and J25 were not detected in any of the isolates. 
Distribution of virulence genes 
The STb-encoding estB gene was the most frequently detected virulence gene. Genes encoding LT1 
(60%), STa (58.6%), F4 (47.1%) and F18 (45.7%) were also widely dispersed among the ETEC 
isolates (Table 1). O141 isolates carried STa, STb, F18 and stx2e, whereas O149 isolates typically 
carried STa, STb, LT1 and F4. 
Phenotypic detection of antimicrobial resistance 
Susceptibility testing revealed that the majority of isolates were resistant to one or more 
antimicrobials (92.8%) and a high proportion showed resistance to three or more classes of 
antimicrobial (64.3%) and were thus classed as MDR. Overall, 34 multidrug resistance profiles were 
identified among the ETEC isolates (Supplementary Table S3). None was resistant to AMC, 
cefotaxime, cefepime, ciprofloxacin or imipenem. Resistance was most frequently detected to 
sulfisoxazole (72.9%), followed by tetracycline (67.1%), ampicillin (50%) and apramycin (44.3%) 
(Table 2). In addition, resistance to cefoxitin (14.3%) and cephalexin (7.1%) also was observed. The 
O141 isolates exhibited resistance to a greater range of drugs in comparison with O149 isolates (Table 
2), and a significantly higher proportion of O141 isolates expressed resistance to ampicillin, 
gentamicin, apramycin, cefoxitin and azithromycin in comparison with O149 isolates (Table 2). 
However, resistance to sulfisoxazole was more frequently detected among O149 (90.3%) than O141 
isolates (51.9%). 
Distribution of antimicrobial resistance genes and integrons 
ARG typing revealed that a high proportion (97%) of ETEC isolates carried at least one of the 
targeted ARGs (Table 1). Genes encoding resistance to aminoglycosides [aac(3)-
IV, aadA, strA and strB] and sulphonamides (sul1) were the most frequently detected ARGs in the 
ETEC collection (Table 1). Of the genes conferring β-lactam resistance, only blaTEM (40%) was 
detected in the ETEC isolates. The most prevalent tetracycline resistance gene was tetA, being 
detected in 35.7% of isolates. ARGs blaTEM, aac(3)-IV, strA and strB were more frequently detected 
among O141 in comparison with O149 (Table 1). In contrast, genes encoding resistance to 
aminoglycosides (aadA), sulphonamides (sul1) and tetracycline (tetA) were commonly detected mong 
O149 isolates (Table 1). None of the following genes was detected in the 
collection: blaSHV; cat1; floR; blaOXA; blaCMY; blaCTX-M; blaMIR-1 or blaACT-1; blaCTX-M-15; aac(3)-
I; blaDHA; blaFOX1–5; and blaMOX or blaCMY. 
The prevalence of integron classes 1, 2 and 3 is shown in Table 1. The class 1 integron (int1) was the 
most common integron among the ETEC strains (68.6% of isolates). This integron was present in all 
but two O149 isolates (93.5%) compared with 40.7% of O141 and 66.7% of NPS isolates. The class 3 
integron was absent in the ETEC collection and only one strain harboured a class 2 integron (1.4%). 
Variation within serogroups 
The O149 isolates were relatively homogeneous with respect to their virulence gene content, plasmid 
type and AMR profile (data not shown). However, the O141 isolates were heterogeneous and broadly 
fell into one of three clusters (Fig. 1). The clusters varied with respect to the carriage of large 
conjugative plasmids (Ia and BM) and small non-conjugative plasmids (colicin E7) as well as their 
virulence factors (Stx2e and LT) and AMR profile (gentamicin and sulfisoxazole). 
 
Discussion 
Neonatal and post-weaning diarrhoea caused by porcine ETEC are amongst the most common 
infectious diseases identified in young piglets. In this study, we investigated the phylogeny and 
molecular epidemiology of Australian porcine ETEC. The findings support three main conclusions 
regarding this pathogen in Australia. First, serogroup O149 isolates, considered to be the most 
common cause of post-weaning diarrhoea, belong to a single, closely related clonal cluster, whereas 
the less commonly encountered serogroup O141 isolates are more heterogeneous in their genetic 
make-up. Second, the study shows that Australian porcine ETEC are distinct from isolates obtained in 
other parts of the world owing to their unique multilocus sequence types and the absence of resistance 
to critically important antimicrobials, including third-generation cephalosporins and fluoroquinolones. 
Lastly, highly promiscuous, broad-host-range IncA/C plasmids were identified among a significant 
proportion of O141 isolates. 
The O149 serogroup (ST100) is considered to be the most common cause of post-weaning diarrhoea 
in Australian pigs. In the present study, combined analysis of O149 genetic diversity together with 
transmissible adaptation traits such as virulence genes, plasmids, bacteriocins and ARGs as assessed 
by PCA (data not shown) demonstrated that O149 isolates belong to a single, closely related clonal 
cluster. This indicates that Australian O149 isolates likely arose from the same clonal lineage and 
have undergone little genetic divergence as they have disseminated throughout the pig industry. 
Demonstrated O149 clonality, together with a relatively conserved transmissible adaptation trait 
profile, supports the persistent clone concept similar to that already described for O25b-ST131, a 
globally disseminated, zooanthroponotic highly virulent and MDR extraintestinal pathogenic E. 
coli (ExPEC) clonal lineage [26,27]. 
In contrast to the O149 findings, isolates belonging to serogroup O141, recognised as the second most 
common ETEC serogroup in Australia, possessed a much more diverse array of transmissible 
adaptation traits despite belonging to the same ST and sharing similar RAPD profiles [4]. This 
confirms the findings from previous studies which proposed that compared with their O149 
counterparts, Australian O141 isolates had developed resistance to a wider range of antimicrobials 
and possessed a wider spectrum of ExPEC-associated virulence genes 
(e.g. bmaE, sfa/focDE, fimH and ihA) [4,9]. The epidemiological significance of these findings is 
currently unclear, although it is quite likely that O141 strains are more adapted to withstand greater 
selection pressure arising from host immunity (virulence genes), antimicrobial use (resistance genes) 
and competition with other E. coli in the gut (bacteriocins). 
Australian porcine ETEC belonged to different multilocus sequence types compared with porcine 
ETEC from other countries. For example, a recent phylogenetic analysis of porcine ETEC revealed 
that O149 isolates from the USA belong to ST165, and the majority of the US porcine ETEC isolates 
belong to ST10, ST23 and ST169 [5]. However, Australian O149 (ST100), O141 (ST1260) and O20 
(ST746) strains are all members of the phylogroup A ST complex 10, as are O149 (ST165) ETEC 
isolates from the USA. The O8 isolates (ST410 and ST90) are members of the ST88/23 complex, a 
group of phylogroup C strains containing many ETEC isolates. Taken together, these results show 
that Australian ETEC isolates, especially serogroups O149, may have evolved in isolation from other 
parts of the world. 
A major finding of this study was that a subset of O141 isolates (14.8%) were the only porcine ETEC 
in the collection found to carry IncA/C plasmids. IncA/C plasmids are highly promiscuous with a 
broad host range and often contain genes that encode resistance to critically important antimicrobials 
including third-generation cephalosporins (blaCMY-2) and carbapenems (blaNDM-1) [25,28,29]. Recent 
studies comparing different IncA/C plasmids have shown that these plasmids have a conserved 
scaffold and a phage integrase–rhs region facilitating the acquisition of new ARGs [25]. The IncA/C 
plasmids identified among the Australian porcine ETEC may therefore be primed to acquire resistance 
to critical antimicrobials such as third-generation cephalosporins through selection pressure arising 
from off-label use of ceftiofur owing to the high prevalence of resistance to other registered 
antimicrobials [9]. 
The AMR profiling revealed a high frequency of multidrug resistance (67.1%) among the ETEC 
isolates. Antimicrobial classes to which a large proportion of the ETEC strains were resistant included 
sulfisoxazole (sul1, 57.1%; and sul2, 21.4%), trimethoprim (dhfrV, 25.7%), aminoglycosides [aac(3)-
IV, 47.1%; aadA, 58.6%; strA, 50%; and strB, 55.7%], ampicillin (blaTEM, 40%) and tetracycline 
(tetA, 35.7%; tetB, 7.1%; and tetC, 5.7%) (Tables 1 and Table 2). Overall, O141 demonstrated 
resistance to a wider range of antimicrobials in comparison with O149 with the exception of 
sulfisoxazole (Table 2). This is likely to be attributed to the variation in the carriage of specific 
plasmids by the different serogroups (Table 1). The absence of resistance to critical antimicrobials 
used in human medicine (fluoroquinolones and third-generation cephalosporins) is noteworthy in 
comparison with data from other countries where resistance to these critical antimicrobials has already 
been identified in porcine ETEC [7,8]. This is likely due to the restriction on the movement of animals 
and food into the country and comparatively stricter regulation of antimicrobial use in food-producing 
animals in Australia [14]. However, the presence of the hypervariable promiscuous resistance 
plasmids IncA/C and I1 among the O141 and NPS isolates indicates that if selection pressure is 
intensified in the future by increased use of third-generation cephalosporins, strains possessing these 
plasmids would be most likely to acquire extended-spectrum or AmpC β-lactamases. These 
resistance-encoding plasmids also have the potential to horizontally transfer to commensal E. coli and 
other Enterobacteriaceae in the pig gut, which routinely enter the environment and the food chain in 
large numbers [30]. It is of concern that such events could lead to exacerbation of resistance in human 
pathogens, as evidenced in other countries [30]. 
Future directions for control of ETEC are informed by several findings from this work. First, the 
dominance of O149 and O141 strains in the population suggests potential for a vaccine-based 
approach to control these serogroups. However, the diverse nature of NPS isolates from Australia 
indicates that development of novel vaccine candidates for the serogroups could be challenging and 
alternative measures may be required to control NPS infections. It is also essential to understand 
whether a high rate of carriage of AMR and fitness genes on hypervariable, highly promiscuous 
plasmids signifies an ability of O141 serogroup porcine ETEC to rapidly evolve and adapt to new 
environments and control measures. 
In summary, this study reveals that Australian porcine ETEC are distinct from isolates obtained in 
other parts of the world with respect to the MLST profile and the absence of resistance to critically 
important antimicrobials, including third-generation cephalosporins and fluoroquinolones. 
Widespread occurrence of virulence and resistance plasmids in the porcine ETEC population is a 
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Table 1. Frequency of Australian porcine enterotoxigenic Escherichia coli isolates possessing specific 





(n = 70) 
Serogroup O149 
(n = 31) 
Serogroup O141 




B/O 4.3 0 0 1 
FIC 30 22.6 37 0.26 
A/C 7.1 0 14.8 0.041 
P 5.7 0 0 1 
FIA 4.3 0 0 1 
FIB 80 96.8 59.3 <0.001 
Y 15.7 6.5 18.5 0.233 
I1 85.7 87.1 100 0.116 
HI1 30 25.8 29.6 0.776 
N 20 16.1 33.3 0.218 
H12 5.7 0 0 1 
LM 5.7 0 0 1 
Bacteriocins 
Colicin E1 1.4 0 0 1 
Colicin E2 2.9 0 7.4 0.212 
Colicin E3 18.6 0 44.4 <0.001 
Colicin E7 20 0 48.1 <0.001 
Colicin Ia/Ib 30 32.3 33.3 1 
Colicin B 17.1 16.1 11.1 0.712 
Colicin M 17.1 16.1 11.1 0.712 
Microcin 
H47 
2.9 3.2 3.7 1 
Microcin M 2.9 3.2 3.7 1 
Virulence genes 
stx2e 21.4 0 51.9 <0.001 
F4 (faeG) 47.1 96.8 0 <0.001 
F6 (fasA) 2.9 0 7.4 0.212 
F18 (fedA) 45.7 0 100 <0.001 
LT1 (eltb) 60 93.5 29.6 <0.001 
F5 (fanA) 7.1 3.2 0 1 
STaP (estA) 58.6 54.8 66.7 0.426 
STb (estB) 84.3 93.5 85.2 0.402 
Antimicrobial resistance genes and integrons
dhfrV 25.7 22.6 18.5 0.756 
aadA 58.6 87.1 40.7 <0.001 
blaTEM 40 19.4 48.1 0.026 





(n = 70) 
Serogroup O149 
(n = 31) 
Serogroup O141 
(n = 27) 
P-value 
(χ2)a 
ereA 7.1 0 0 1 
aphA1 27.1 16.1 18.5 1 
aac(3)-IV 47.1 25.8 66.7 0.003 
tetA 35.7 45.2 14.8 0.022 
tetB 7.1 6.5 0 0.494 
tetC 5.7 12.9 0 0.116 
sul1 57.1 83.9 37 <0.001 
sul2 21.4 9.7 29.6 0.091 
strA 50 29 63 0.017 
strB 55.7 41.9 55.6 0.43 
int1 68.6 93.5 40.7 <0.001 
int2 1.4 0 0 1 
 



















Table 2. Frequency of Australian porcine enterotoxigenic Escherichia coli isolates possessing single 







(n = 70) 
Serogroup O149 
(n = 31) 
Serogroup O141 
(n = 27) 
P-value 
(χ2)a 
AMP 50.0 25.8 66.7 0.003 
AZM 25.7 12.9 40.7 0.019 
CEX 7.1 3.2 11.1 0.329 
NAL 2.9 3.2 0 1 
SSX 72.9 90.3 51.9 0.001 
TIM 11.4 12.9 11.1 1 
TMP 40.0 48.4 29.6 0.184 
TET 67.1 74.2 55.6 0.172 
APR 44.3 25.8 63.0 0.007 
NEO 24.3 22.6 11.1 0.311 
CHL 17.1 16.1 25.9 0.518 
GEN 34.3 16.1 59.3 <0.001 
FOX 14.3 3.2 29.6 0.009 
 
AMP, ampicillin; AZM, azithromycin; CEX, cefalexin; NAL, nalidixic acid; SSX, sulfisoxazole 
(sulfafurazole); TIM, ticarcillin/clavulanic acid; TMP, trimethoprim; TET, tetracycline; APR, 
apramycin; NEO, neomycin; CHL, chloramphenicol; GEN, gentamicin; FOX, cefoxitin. 












Fig. 1. Principal coordinate analysis (PCA) of phenotypic antimicrobial resistance, antimicrobial 
resistance genes, virulence genes, integrons, plasmid replicons and bacteriocins detected among 
serogroup O141 isolates. Red, green and blue circles represent the three clusters of O141 isolates. 
Coordinates of some of the individual traits that distinguish the clusters are also present (plasmid 
replicons, IncN and IncHI1; colicins, Ia, E7 and BM; virulence factors, Stx2e and LT1; and 
antimicrobial resistance, gentamicin and sulfisoxazole). For example, the strains indicated by red 
circles are more likely to harbour IncN plasmids or encode colicin E7 than are strains in the other 
clusters. (For interpretation of the references to colour in this text, the reader is referred to the web 
version of the article.) 
 
 
 
 
 
 
